|
Kearns-Sayre Syndrome
|
C14.280.238.510 |
|
|
Genome-Wide Association Study
|
E05.318.416.249 |
|
|
Molecular Epidemiology
|
E05.318.416 |
|
|
Dyspareunia
|
C13.351.500.665.313 |
|
|
Sexual Dysfunction, Physiological
|
C13.351.500.665 |
|
|
Carbohydrate Metabolism
|
G02.111.158 |
|
|
Connecticut
|
Z01.107.567.875.550.200 |
|
|
New England
|
Z01.107.567.875.550 |
|
|
Synaptic Transmission
|
G11.561.830 |
|
|
Fanconi Anemia Complementation Group D2 Protein
|
D12.776.313.812 |
|
|
Brain Chemistry
|
G02.111.150 |
|
|
Fluoroacetates
|
D02.241.081.018.285 |
|
|
Lithotripsy, Laser
|
E02.600.500 |
|
|
Lithotripsy
|
E02.600 |
|
|
Methanococcus
|
B02.200.538.525.500 |
|
|
Granulocyte Colony-Stimulating Factor
|
D23.529.374.410.240.350 |
|
|
Colony-Stimulating Factors
|
D23.529.374.410.240 |
|
|
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
|
D26.310.375 |
|
|
Dimenhydrinate
|
D26.310.368 |
|
|
Local Government
|
N03.540.348.750 |
|
